MAPT and Alzheimer disease: In our previous publication [9], we demonstrated that the association or binding between the two AD-involved proteins, APP and Tau, can be disrupted by a mixture of two peptides APP1 (aa 390–412 HFQKAKERLEAKHRERMSQVMRE) and Tau1 (aa19–34 GLGDRKDQGGYTMHQD).